Deep Braining...
TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
SELLAS Life Sciences Group, Inc. Common Stock (SLS)
SELLAS Life Sciences Group, Inc. Common Stock
XNAS:SLS
1.63
11.61%
Ask
$17.60 - 20.00
Bid
$1.59 - 100.00
Low
$1.47
High
$1.64
Open
$1.47
Prev Close
$1.46
52W High
2.48
52W Low
0.77
Volume
2141950
Avg Vol (3m)
3282828.8
Float
142004703.06
Chart
TendieTensor AI Analysis
Company
Asset Type: Common Stock
SIC Code: 2834
Sector: Health Technology
Industry: Pharmaceuticals: Major
Date Listed: 03/12/2008
Primary Exchange: XNAS

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Phone: (646) 200-5278
Address: 7 Times Square
Address 2: Suite 2503
City: New York
State: NY
Postal Code: 10036
Website
TendieTensor AI Analyst Recommendation: —
Fundamentals
Total Employees:
15
P/E (TTM)
-5.650000
P/B (TTM)
4.440670
EPS
-0.06
Round Lot
100
Composit FIGI
BBG000VC77H7
Share Class FIGI
BBG001T223C9
Share Class Shares Outstanding
105.30M
Weighted Shares Outstanding
147.44M
Technicals
RSI (14)
MACD Line
MACD Signal
SMA 20
SMA 50
EMA 50
Trend
Short Interest
—
Days to Cover
— —
Higher = harder to cover
Short Interest Δ
—
Prev: —
Short Volume Ratio (Today)
— —
5D avg: —
Squeeze Score (0–100)
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks

Based on the portfolios of people who own SLS. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.